{
    "2020-10-14": [
        [
            {
                "time": "",
                "original_text": "考虑了良久，为何定投选择了科技50策略指数？",
                "features": {
                    "keywords": [
                        "科技50",
                        "策略指数",
                        "定投"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "凯莱英定增一波三折终成行 发行价翻倍高瓴坚定布局A股医药版图",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "定增",
                        "发行价翻倍",
                        "高瓴",
                        "医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}